Profile for France Patent: 20C1003
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for France Patent: 20C1003
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 8,969,336 | Nov 28, 2032 | Astellas | XOSPATA | gilteritinib fumarate |
| 9,487,491 | Jul 28, 2030 | Astellas | XOSPATA | gilteritinib fumarate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
